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Abstract: The American Lung Association of Minnesota (ALAMN) was granted access to a 2004 
administrative claims data from an upper mid-Western, independent practice association model 
health plan. Claims information, including demographics, prevalence, medication and oxygen 
therapy, and health care utilization, was extracted for 7,782 patients with COPD who were 40 years 
of age and older. In addition, ALAMN conducted a survey of 1,911 patients from Minnesota diag-
nosed with COPD. The survey queried the patients about demographics, treatment, medications, 
limitations, wants, and needs. This article compares and contrasts the information gained through 
the health plan administrative claims database with the ﬁ  ndings from the COPD patient survey 
in areas of age, gender, types of provider primarily responsible for COPD care, spirometry use, 
medication therapy, pulmonary rehabilitation, oxygen therapy, and health care utilization. Primary 
care practitioners provided a majority of the COPD-related care. The claims evidence of spirometry 
use was 16%–62% of COPD patients had claims evidence of COPD-related medications. 25% 
of patients reported, and 23% of patients had claims evidence of, a hospitalization during the 
observation year. 16% of patients reported using pulmonary rehabilitation programs. The results 
indicate there is an opportunity to improve COPD diagnosis and management.
Keywords: chronic obstructive pulmonary disease, oxygen therapy, medication therapy, 
spirometry, chronic care, assessment
Introduction
Chronic obstructive pulmonary disease (COPD) is characterized by poorly irreversible 
airﬂ  ow obstruction. The airﬂ  ow limitation usually is progressive and associated 
with an abnormal inﬂ  ammatory response related to exposure to noxious substances 
(GOLD 2006) and is seen most commonly as chronic bronchitis and emphysema. 
Nearly 10.7 million US adults have been diagnosed with COPD, but as many as 
24 million US adults have evidence of impaired lung function (Carlson et al 2006). 
The disease burden from COPD is marked by signiﬁ  cant functional disability, severe 
respiratory symptoms, and a pronounced impact on quality of life (Vermeire 2002). 
COPD is the fourth leading cause of death in the United States, claiming the lives of 
more than 120,000 Americans in 2002 (Carlson et al 2006). In 2004, the economic 
burden of COPD in the US was estimated at $37.2 billion (ALA 2005). Patients with 
COPD utilize a statistically signiﬁ  cantly higher proportion of health care resources, 
including ofﬁ  ce visits, inpatient hospitalizations, and prescription drugs than patients 
who had other nonrespiratory conditions (Shaya et al 2006).
Published estimates of the prevalence of COPD vary greatly. The prevalence of 
Maryland Medicaid enrollees older than 45 years of age who were continuously enrolled 
between January 1, 2001 and December 31, 2003 and who had at least one medical 
claim pertinent to COPD in their primary diagnosis was 1.4% (Shaya et al 2006). International Journal of COPD 2008:3(3) 416
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An older study conducted in Berlin, New Hampshire reported 
the prevalences of COPD (deﬁ  ned as forced expiratory volume 
in the ﬁ  rst second [FEV1]  60% predicted) ranging from 3.1% 
to 21.7% in men in the community where occupational risk 
factors could have been relevant, and 6.2% to 13.9% in women 
(Ferris and Anderson 1962). In Tecumseh, Michigan, 14% of 
adult men and 8% of adult women had chronic bronchitis, 
obstructive airway disease, or both (deﬁ  ned as FEV1   65% 
predicted with an accompanying FEV1/ forced vital capacity 
[FVC] ratio of 80%) (Higgins et al 1984). In Glenwood Springs, 
Colorado, a community screening program found that 17% of 
men had chronic bronchitis and 13% had COPD; 10% of the 
women had chronic bronchitis and 4% had COPD (deﬁ  ned as 
FEV1/FVC ratio,  60% with dyspnea, cough, expectoration, 
or wheeze) (Mueller et al 1971). In the NHANES III study, 
a national representative sample of adults residing in the US, 
8.5% reported being diagnosed by a physician with obstructive 
lung disease (Mannino et al 2000).
COPD is also a burden to individuals under 65 years 
of age who are in the workforce and who are likely to be 
enrolled in a commercial health plan (Tinkelman et al 2005). 
In a retrospective analysis of a large dataset of patients with 
COPD enrolled in a disease management program, almost 
half (49.7%) were less than 65 years of age. In addition, 
46.1% were employed and missed an average of 4.6 days of 
work the previous six months (Tinkelman and Corsello 2003). 
Similarly, in a retrospective analysis of a managed care 
research database, about half of the patients with COPD were 
in the 45 to 64 year age group (Kesten 2001).
While COPD is the fourth leading cause of death in the 
United States, there is a lack of data to inform the decisions of the 
public health, medical, and policy communities (Voekel 2000; 
Barr et al 2005; Mannino 2005,). The purpose of this study is 
to assess the concordance of documented health care utilization 
with patient reported use, needs, and wants regarding COPD in 
an effort to provide a baseline description of COPD in Minnesota 
and guide the programmatic efforts of the ALAMN.
Methods
Two data sources were utilized: the ﬁ  rst, a managed care 
administrative database, and the second, a mailed survey to 
Minnesota patients identiﬁ  ed with COPD.
Administrative data
This observational cohort study utilized medical and pharmacy 
administrative claims data from a large, independent practice 
association model, Midwest health plan (1.25 million insured 
lives including commercial, Medicaid, and Medicare qualiﬁ  ed 
enrollees). Subjects for this study were identiﬁ  ed using medical, 
pharmacy, and enrollment ﬁ  les. A member, 40 years of age or 
older during 2004, was included if there was: (1) continuous 
enrollment from January 1, 2004 to December 31, 2004 with no 
gaps of enrollment greater than 30 days; (2) there was at least 
1 claim with a diagnosis of COPD (491.xx chronic bronchitis; 
492.xx emphysema; 496.xx chronic airway obstruction, not 
elsewhere classiﬁ  ed) in any claims diagnosis position; (3) the 
claim with the associated diagnosis originated from a “medical” 
place of service (ie, place of service codes at which a patient 
would likely receive care supervised by a physician).
Variables of interest were determined from the linked data 
ﬁ  les and included: age, gender, provider with responsibility 
for COPD care, hospital admissions, emergency department 
admissions, ofﬁ  ce visits, drug therapy for COPD (inhaled 
corticosteroids, anticholinergic agents, bronchodilators (oral 
or inhaled), combination therapies, oral corticosteroids, 
theophylline, and cromolyn), spirometry, and oxygen 
therapy. See Table 1. SAS version 9 (SAS Institute, Cary, 
NC) was used for all claims analysis.
Patient survey
Survey development
Questions from the Seattle Obstructive Lung Disease 
Questionnaire (Fan et al 2002) were selected based on survey 
Table 1 Coding criteria for COPD claims
ICD-9 codes Medical place of service codes 
(US Federal deﬁ  nitions)
491.xx chronic bronchitis 11 Ofﬁ  ce
492.xx emphysema 12 Patient’s home
496.xx chronic airway 
obstruction, not elsewhere 
classiﬁ  ed
21 Inpatient hospital
23 Emergency room hospital
26 Military treatment facility
Spirometry 31 Skilled nursing facility
CPT-4 94010-94039 32 Nursing facility
ICD-9-PROC 89.3 33 Custodial care facility
50 Federal qualiﬁ  ed health center
Oxygen Therapy 51 Inpatient psychiatric facility
HCPCS E0424-E0444; E1390 52 Psychiatric facility with partial 
hospitalization
53 Community mental health 
center
56 Psychiatric residential treatment 
center
71 State or local public health clinic
72 Rural health clinicInternational Journal of COPD 2008:3(3) 417
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length, question content, and psychometrics. ALAMN added 
additional questions about medication use, physician care, 
services accessed, barriers to care, and educational or other 
needs of the patient. Lastly, ALAMN included an analog 
scale for dyspnea in the past 24 hours.
Experts in lung health research and clinical practice were 
consulted in the development of this questionnaire. The ques-
tionnaire was pilot tested twice in October 2005 with two 
groups of COPD patients (n = 40) who attend ALAMN lung 
health support groups. Final changes were made to the question-
naire based on feedback from experts and the pilot testing.
Site recruitment and enrollment
Twelve medical practices across Minnesota were recruited 
to partner with ALAMN for survey distribution. Sites were 
selected based on a convenience sample. Clinic sites included 
both public/academic and private specialty and primary care 
practices located in the metropolitan area of the Minneapolis/
St. Paul and Greater Minnesota.
Institute Review Board approval was obtained from 
all institutions requiring it. Each site identiﬁ  ed all patients 
with COPD (deﬁ  ned as ICD-9 code of 491.xx, 492.xx, and 
496.xx). Survey packets were prepared at the ALAMN and 
then transferred to each site for conﬁ  dential labeling. Sites 
mailed to all their patients meeting the diagnostic criteria, 
with the exception of three sites with too large a patient popu-
lation. In these cases, the total survey number was capped at 
a random sample of 1000. The smallest number of surveys 
mailed to any site was 100. Surveys were mailed with prepaid 
return envelope and a $1 bill incentive (with exception of one 
site that did not allow the incentive). In total, 6,860 surveys 
were mailed; 590 were returned as undeliverable. The usable 
response rate was 27.9% (n = 1,911). The response rate varied 
by site, ranging from 8% to 52.3%.
Data analysis
Data was hand entered into Remark Ofﬁ  ce OMR, Version 5.5 
(Philadelphia, PN). Data entry validation was conducted on 
every 50th survey. The accuracy data entry was nearly 100%. 
Data was analyzed using SPSS version 15.0 for Windows 
(SPSS Inc., Chicago, IL).
Results
Demographics
A total of 7,782 members, 40 years of age or older, were 
identiﬁ  ed with COPD using the health plan claims criteria 
previously described. Approximately 56% of members 
with COPD were female; 78% were 60 years of age or 
older. This represents a COPD prevalence rate of 38.3 per 
1,000 continuously enrolled members on an annual basis 
(See Figure 1). While the overall prevalence among women 
was slightly higher than men (39.5 per 1,000 and 37.0 per 
1,000 respectively), this relationship varies by age. At the age 
of 40–49, there were statistically signiﬁ  cantly more claims 
for females with COPD than males. At age 60–69, the gender 
prevalence was similar. In the oldest age group (80  years 
or older) the prevalence of COPD among continuously 
enrolled males exceeds the prevalence among continuously 
enrolled females by a factor of approximately 1.6 times 
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Figure 1 Prevalence of COPD by age and gender.International Journal of COPD 2008:3(3) 418
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completed the Lung Health Questionnaire, 53% were male 
and 47% were female; 82.% were 60 years of age and older; 
and 19.1% were 80 years of age and older.
Provider type responsible
for COPD care
Analysis of claims histories revealed that a family practice 
provider was identiﬁ  ed as responsible for COPD care for 
35% of members identiﬁ  ed with COPD; internists for 28%; 
pulmonary disease specialists for 9%; and 18% were cared 
for by a variety of other subspecialists.
Of the patients that completed the Lung Health 
Questionnaire, 51% identiﬁ  ed a family practice physician as 
responsible for their COPD care, 13% identiﬁ  ed internists, 
27% identiﬁ  ed a pulmonary specialist, and 9% identiﬁ  ed a 
variety of other health care providers. When asked if the 
patient had ever seen a lung health specialist or pulmonolo-
gist for their breathing problems, 35% of patients completing 
the Lung Health Questionnaire indicated no.
Spirometry
There were 1,258 members with COPD (16%) who had claims 
for a spirometry test during the observation year. This is equiva-
lent to one out of every 6 patients with COPD. Of health plan 
members with COPD and having a claim for a COPD-related 
medication therapy, 19.4% had a claim for spirometry.
Of the patients that completed the Lung Health 
Questionnaire, 60% (1183) answered that they had at least 
one breathing test for their lungs (“where you blow hard into 
a tube, also called spirometry”) in the past 12 months.
Drug therapy for treatment 
of COPD
Among the 7,782 members identiﬁ  ed with COPD, 38% 
were without pharmacy claims for a COPD-related drug 
therapy; bronchodilator (ie, albuterol) use was reported 
for 38%; combination therapies (ie, both beta-agonist plus 
anticholinergic and beta-agonist plus inhaled steroids) for 
36%; inhaled corticosteroids (ie, ﬂ  uticisone and budisinide) 
for 13%; anticholinergic agents (ie, ipitrompium) for 14%; 
oral steroids (ie, prednisone) for 29%; theophylline for 2%; 
and cromolyn and nedocromil for 0.1%.
Among patients using inhaled corticosteroids, 6% had 
claims evidence of only inhaled corticosteroids. Among 
the patients using oral steroids, 19% had claims evidence 
relying only on these agents. Anticholinergic agents were 
the only therapy with claims evidence for 5% of patients 
with anticholinergic claims. Bronchodilators were the only 
therapy with claims evidence for 19% of patients with 
bronchodilator claims.
Of the patients that completed the Lung Health Question-
naire, the following types of medications were reported as 
being currently taken for their lung condition: bronchodilators 
52%; combination medication 47%; inhaled steroids 30%; 
anticholinergic agents 27%; prednisone by mouth 12%; and 
other not speciﬁ  ed by patient 20%. Five percent of respondents 
reported that they did not know the type of medication that 
they were taking daily for their lung condition.
Health care utilization
During the observation year, 23% of the health plan 
members with COPD had at least one hospitalization for 
health concerns, whereas 10% of the general population of 
continuously enrolled members without COPD had at least 
one hospitalization. This compares to the 25% of respondents 
to the Lung Health Questionnaire that reported they had been 
hospitalized at least once in the past 12 months.
Utilization of emergency department services, however, 
was lower among members with COPD than among the general 
population of continuously enrolled members without COPD 
(8.4% vs 13.2% with at least one ED admission for health 
concerns). The percentage of COPD members with at least one 
ofﬁ  ce visit was also lower than the general population of con-
tinuously enrolled members (66% and 85%, respectively).
Of the 1,991 patients that completed the Lung Health 
Questionnaire, 39% reported that they had made at least one 
unscheduled visit to the doctor’s ofﬁ  ce, urgent care, or the 
emergency department because of their COPD.
Use of pulmonary rehabilitation
Pulmonary rehabilitation could not be separately identi-
ﬁ  ed in the health plan administrative claims data. Of the 
patients who completed the Lung Health Questionnaire, 
however, 2% reported currently attending a pulmonary 
rehabilitation program; an additional 1% were currently in a 
pulmonary maintenance program; and 13% have previously 
attended a pulmonary rehabilitation program. Approximately 
66% of COPD patients who completed the Lung Health 
Questionnaire reported that they had never been offered or 
heard of pulmonary rehabilitation programs.
Oxygen therapy
Claims for any type of oxygen therapy were identiﬁ  ed for 
22% of members with COPD. Among these members, 35% 
had claims for oxygen concentrators, 32% for compressed 
gas, and 33% for liquid oxygen.International Journal of COPD 2008:3(3) 419
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Of the patients that completed the Lung Health 
Questionnaire, 31% reported that they currently use oxygen 
at home to treat their lung condition. Of those that reported 
using an oxygen system, 47% reported using oxygen concen-
trators; 22% compressed gas; 18% liquid oxygen; and 13% 
home-ﬁ  ll systems.
Discussion
The results of the administrative claims study indicate a 
COPD prevalence rate of 38.3 per 1,000 continuously enrolled 
members in this independent practice association model 
health plan. The manner in which prevalence rates increased 
as aged increased, and were higher among older males than 
older females, is consistent with published literature. This 
study’s prevalence rate is two times higher than that reported 
by Shaya and colleagues (2006) among Maryland Medicaid 
enrollees. In that study, selection criteria included members 
who were continuously enrolled between January 1, 2001 
and December 31, 2003 and who had at least one medical 
claim pertinent to COPD in the primary diagnosis. However, 
it is likely this Medicaid only population would have lower 
prevalence due to the younger average age of Medicaid 
enrollees.
It is important to note that reported prevalence varies 
across published studies depending on the claims identiﬁ  cation 
method used. This study used selection criteria of one year of 
continuous enrollment, and applied ICD-9-CM diagnosis cod-
ing from places of service judged to be those where patients 
would most likely be in contact with a physician. Clearly, a 
more standardized deﬁ  nition of health plan administrative 
database selection criteria for patients with COPD is needed.
Approximately 63% of patients identiﬁ  ed in the health 
plan data were seen by a primary care physician (either a 
family practitioner or internist) for their COPD care. This 
was consistent with the 67% of patients who completed 
the Lung Health Questionnaire indicating that a generalist 
(family practice, nurse practitioner, physician assistant, or 
internist) was primarily responsible for the management of 
their lung condition.
Only one out of six members with COPD in the 
administrative data had claims evidence of spirometry during 
the study year, suggesting that this tool may be underutilized. 
Literature suggests that underutilization of spirometry in 
COPD cases may be common. Chapman and colleagues 
(2001) surveyed 192 primary care physicians using a 
hypothetical case presentation and structured interview. Only 
22% of the physicians interviewed indicated that they would 
have requested spirometry after the initial presentation. In an 
earlier study based on one-on-one interviews with primary care 
physicians, Kesten and Chapman (1993) concluded that pri-
mary care practitioners underutilized spirometry as a screening 
tool. Access to spirometry, training on implementation and 
interpretation, and education on its relevance was identiﬁ  ed 
as a major goal for primary care physicians by COPD experts 
from the United States and Europe (Voelkel 2000).
Sixty percent of respondents to the Lung Health Question-
naire reported having a spirometry test in the past year. This 
is a frequency much higher than the administrative claims 
data indicate. The difference in these two results might be 
explained by either patient perception of a lung test, even 
though the questionnaire offered a rudimentary deﬁ  nition of 
spirometry (ie, “Had a breathing test for your lungs where 
you blow hard into a tube [also called spirometry”]) or the 
low survey response rate of 28%. In addition, patients who 
choose to complete the Lung Health Questionnaire might be 
those who are more aware of their disease and/or are being 
monitored more carefully by their physician.
Bronchodilators and combination therapies were the 
most frequently reported medication therapy for both 
administrative claims data and Lung Health Questionnaire 
respondents. Bronchodilator therapy is recommended as the 
ﬁ  rst line therapy for all patients with COPD (GOLD 2006). 
It is of concern that 38% of patients with COPD did not 
have claims for any COPD-related drug therapy. While it 
is true that patients can obtain medications from sources 
other than insurance (eg, physician samples, out-of-pocket 
purchases, or mail order outside of the US), given the cost of 
these medications, it is not likely that patients would choose 
to bypass their prescription beneﬁ  t. This ﬁ  nding should not 
necessarily be interpreted as a failure of the physician to 
prescribe medications; rather, it may reﬂ  ect patient choice not 
to acquire them. Claims data cannot measure prescriptions 
written and not ﬁ  lled.
Equally concerning, 19% of patients with COPD only 
had claims evidence for oral steroids, 6% for inhaled 
cortiosteroids only, and 5% for anticholinergic agents only. 
These findings are not consistent with national COPD 
guidelines, which indicate that bronchodilator medications 
are central to the management of COPD. Bronchodilators 
should be prescribed on an as-needed or on a regular basis 
to prevent or reduced symptoms (GOLD 2006).
The results from the administrative claims data indicated 
that patients with COPD had hospitalizations (25%) more 
frequently than they had emergency department visits (8%). 
This is consistent with Shaya and colleagues (2006), who 
found on average 25 claims for inpatient hospitalization over International Journal of COPD 2008:3(3) 420
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a three year period and at most, one claim for an emergency 
department visit. Emergency department visits for COPD 
may be low because those COPD patients who present in 
the emergency department and are subsequently admitted 
are not reﬂ  ected in the emergency department rate.
Only 16% of respondents to the Lung Health Question-
naire have attended or were currently participating in a pul-
monary rehabilitation program. Pulmonary rehabilitation has 
well-documented beneﬁ  ts, such as strength, endurance, and 
conﬁ  dence, as well as reducing dyspnea. However, it is unde-
rutilized because it is often not reimbursed and is not made 
available to most COPD patients (Pierson 2004). Data from 
the Lung Health Questionnaire conﬁ  rm that pulmonary reha-
bilitation is not only underutilized, but patients lack awareness 
about its existence. Nearly two-thirds of the respondents had 
not heard of pulmonary rehabilitation or had not been offered 
this as an option by their health care provider.
Twenty-two percent of the patients have claims evidence 
and 31% of the respondents to the Lung Health Questionnaire 
report using oxygen. If guidelines are being followed, this would 
mean that 22%–31% of these patients have severe COPD, and 
therefore should be optimally medicated. It would require 
further study to determine if oxygen therapy was being used 
appropriately and/or if medication was generally optimal.
Based on these findings, it is clear that there is an 
opportunity to improve COPD diagnosis and management by 
focusing on primary care. This focus should include promo-
tion of national care guidelines and professional education 
related to COPD and respiratory health. A systems approach 
will be needed to obtain signiﬁ  cant improvement in COPD 
care. The introduction of a chronic care model for COPD 
may include: accurate patient identiﬁ  cation; training of and 
decision-support tools for health care professionals related to 
spirometry, COPD diagnosis and appropriate treatment; a mul-
tidisciplinary approach to patient care and education; guide-
lines-based medication and oxygen therapy use; improved 
clinic ﬂ  ow systems; and provider performance feedback, with 
appropriate incentives, on process and outcome measures.
Limitations of this study
Several limitations to this study exist. Claims data limitations 
include only one year of administrative claims and inclusion of 
person’s with managed care coverage, which does not generally 
include veterans. There is also a dependence on the accuracy 
of coding and an individual’s choice to utilize health care ser-
vices for their disease. Lung Health Questionnaire limitations 
included a 28% response rate and the inability to test for repre-
sentatives of the respondents. Authors cannot comment on the 
severity of COPD disease, the prescribing pattern of physicians, 
whether patients were appropriately managed by primary care 
providers, or the need for referrals to specialists.
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Appendix A List of lung health questionnaire partner clinics
 1. Alexandria  Clinic
  2.  Broadway Clinic (formerly North Memorial Family Practice)
  3.  Cass Lake Hospital and Clinics
 4. Health  Partners
 5. Immanuel  St.  Joe’s
 6. Mayo  Clinic
 7. Multicare  Associates
  8.  Olmstead County Medical Center
  9.  St. Luke’s Clinic – Duluth
  10.  St. Mary’s Duluth Clinic
  11.  University of Minnesota
  12.  Minneapolis Department of   Veterans Affairs Medical Center